Expression of homeotic (Hox) genes is established early in development and is maintained epigenetically through many cell generations by the trithorax group factors. However, certain transitions in cell fate require a switch in Hox gene transcription from the "on" to the "off" state. For example, during blood cell development (hematopoiesis) in humans, expression of the HOXA9 gene is maintained in stem and progenitor cells but is turned off during terminal differentiation. Failure to silence HOXA9 blocks the maturation of blood cells, which results in expansion of self-renewing progenitor cells, leading to leukemia (reviewed in Slany, 2009) . The human trithorax factor MLL1 maintains HOXA9 expression in stem and progenitor cells but is also required for switching it off during blood cell maturation (Slany, 2009) . Chromosomal translocations of the MLL1 gene produce fusion proteins, which support the activation of HOXA9 expression but not the transition to the repressed state of HOXA9. This results in leukemia, with 40% of infants surviving 5 years after diagnosis with MLL (reviewed in Slany, 2009) .
Although the role of MLL1 in the positive regulation of gene expression has been well studied, much less is known about the mechanisms by which MLL1 controls the switch-like behavior of its target genes. MLL1 is known to bind to repressor proteins, such as histone deacetylases, and this interaction is stabilized by the association of its PHD3 finger with a nuclear cyclophilin, CyP33 (Xia et al., 2003) . Indeed, the PHD3 finger of MLL1 is critical for inducing the epigenetic switch during hematopoiesis because loss of the PHD3 finger is necessary for immortalization of hematopoietic stem cells (Chen et al., 2008) . Now in a tour-de-force structural study in this issue, Wang et al. (2010) shed light on the molecular mechanism by which MLL1's PHD3 domain integrates distinct regulatory inputs by recognizing two ligands simultaneously: the trimethylated lysine 4 of histone H3 (H3K4me3) and the RNA recognition motif domain of CyP33 ( Figure  1C) . Interestingly, the bromodomain of MLL1, which is adjacent to the PHD finger, stimulates and inhibits binding of MLL1 to H3K4me3 and to CyP33, respectively. Further, cis-trans isomerization of a proline residue in MLL1's The MLL1 (mixed lineage leukemia 1) protein, which is often disrupted in leukemia, both activates and represses Hox genes during hematopoiesis. Now, Wang et al. (2010) demonstrate that the cyclophilin CyP33 underpins this regulatory switch by altering the state of MLL1 through cis-trans proline isomerization in the linker region between MLL1's third PHD finger and bromodomain. The histone methlytransferase MLL1 (mixed lineage leukemia 1) can both activate and repress the expression of HOX genes. (A) MLL1 binds to the N-terminal polypeptide tail of histone 3 (H3) trimethylated on lysine 4 (H3K4me3) (Wang et al., 2010) . In this context, MLL1 acts as a transcriptional activator, both reading and writing H3K4me3 chromatin marks. linker region, which connects the PHD3 domain and bromodomain, overcomes this inhibitory effect.
PHD fingers recognize various specific methyl-lysine residues on histones, and interactions with tri-or dimethylated lysine 4 on histone 3 (H3K4me2/3) appear particularly favored by this structural fold (Ruthenburg et al., 2007a) . Wang et al. now demonstrate in vitro that the PHD3 finger of MLL1 also binds to peptides containing the H3K4me2/3 marks. Curiously, this interaction is quite weak but increases by >10-fold when the adjacent bromodomain is present ( Figure 1A ). Together these domains are referred to as the PHD3-bromo cassette. Wang et al. solved X-ray crystal structures of MLL1's PHD3-bromo cassette, both alone and in complex with H3K4me3 peptides. Like other proteins that read histone methyl-lysine marks, MLL1 recognizes a methylated lysine through aromatic residues in the PHD3 finger that form an "aromatic cage." However, the cage of MLL1 is unusual, as one tyrosine residue (Tyr1581) completes the cage by flipping inwards upon binding to a methyl-lysine. Moreover, the PHD3 finger undergoes conformational changes upon interaction with H3K4me3 to stabilize the peptide within the binding pocket ( Figure 1A ). Such dynamic huddling of the histone tail has not been seen in other PHD finger structures.
MLL1 itself is a histone methyltransferase that methylates lysine 4 of histone 3 through its enzymatic SET domain (Ruthenburg et al., 2007a) . Why then does MLL1 recognize its own enzymatic product? Direct coupling of the "reading" and "writing" of H3K4me3 may stabilize the association of MLL1 with its targets and provide a positive feedback loop that reinforces transcriptional activation. Indeed, the results of Wang et al. (2010) and those of another study by To address this question, Wang and colleagues characterized interactions between MLL1's PHD3 finger and CyP33 (Xia et al., 2003) . In biochemical assays, the PHD3 finger alone readily associates with the RNA recognition motif domain of CyP33; however, the PHD3-bromo cassette surprisingly interacts only with the full-length CyP33 protein and not with the isolated RNA recognition motif domain. Therefore, the authors hypothesize that the bromodomain inhibits association of the PHD3 finger with the RNA recognition motif domain and that the enzymatic activity of the proline peptidyl isomerase domain of CyP33 relieves this inhibition. To test this, they characterized the interaction surface between the PHD3 finger and the RNA recognition motif domain using nuclear magnetic resonance (NMR). Indeed, PHD3 binds to the RNA recognition motif domain using a surface occluded by MLL1's bromodomain in the crystal structure of the PHD3-bromo cassette.
How does the full-length CyP33 overcome this inhibitory effect? A linker region with a proline residue connects the PHD3 finger and bromodomain; when not associated with CyP33, the proline adopts a cis configuration and the orientation of the bromodomain occludes the region of the PHD finger that binds to the RNA recognition motif domain ( Figure 1A ). However, a cistrans isomerization of the linker proline by CyP33 alters the position of the bromodomain relative to the PHD3 finger and in turn exposes the PHD3 finger's binding surface for the RNA recognition motif domain (Figures 1B and 1C) . Interestingly, in the permissive trans-conformation, the PHD3-bromo cassette can bind simultaneously to the RNA recognition motif domain and to the H3K4me3 peptide.
These structural studies provide an elegant example of how proline isomerization can control the association of a methyl-lysine reader with an additional protein ligand. However, is this intricate interplay important for regulation of HOX genes by MLL1? Although the effects are modest, likely reflecting the complex regulation of HOX genes, overexpression of wild-type CyP33 decreases acetylation of HOXA9 and HOXC8 promoters and expression of these genes. Meanwhile, overexpressing mutant CyP33 that cannot bind to the PHD3 domain or that lacks isomerase activity does not result in repression of HOX gene transcription.
Many questions remain, especially concerning the involvement of RNA in this epigenetic switch. RNA binding stimulates isomerase activity of CyP33, and the PHD3 finger of MLL1 competes with RNA for the binding surface on CyP33 (Wang et al., 2008; Hom et al., 2010) . However, the specific RNAs that bind to the RNA recognition motif domain of CyP33 in vivo are still unknown. Are they nascent RNAs that perhaps contain the AAUAAA polyadenylation signal (Wang et al., 2008; Hom et al., 2010) , or are they trans-acting, noncoding RNAs? Furthermore, do RNA molecules contribute to targeting, stabilization, or release of CyP33 from MLL1?
Finally, how does CyP33 regulate the switch from HOXA9 activation to repression during the terminal differentiation of hematopoietic cells? As the association of CyP33 with chromatin appears largely independent of MLL1, is CyP33 regulated by its recruitment or enzymatic activity during this transition? Moreover, given that MLL1 reads and writes H3K4me3 marks simultaneously, understanding how CyP33 modulates this potentially self-perpetuating loop will be a fascinating line of future inquiry. In summary, Wang et al. (2010) provide a tantalizing insight into the structural intricacies of MLL1's regulatory switch, demonstrating how small details sometimes have a large impact.
The amount of variation in the human genome is tremendous! Such variation consists primarily of single nucleotide variations (SNVs) and copy number variations (CNVs). CNVs are extensive in the human genome, but their importance has only recently been appreciated with genome-wide technologies that can assay for CNVs and other structural changes such as inversions that deviate from the "normal" diploid state. Personal genome sequences have revealed that each one of us differs from the reference haploid human genome by about 3.0-3.5 × 10 6 single nucleotide variants (Lupski et al., 2010) . Regarding the 6 × 10 9 base pairs (bp) of the diploid human genome, recent studies reveal that each of our genomes has an average of ?1000 CNVs ranging from about 500 bp to 1.3 Mb in size (median is 2.9 kb) (Conrad et al., 2010) . The mechanisms underlying the genomic rearrangements that result in CNVs are diverse (Hastings et al., 2009 ). This issue of Cell reports three studies from different groups, which independently demonstrate that highly repetitive sequences in the human genome such as the LINE-1 and Alu elements contribute significantly to structural variations (Beck et al., 2010; Huang et al., 2010; Iskow et al., 2010) (Figure 1) . Furthermore, they show that many endogenous LINE-1 sequences undergo active transposition in both germline and somatic cells to a much greater degree than previously thought. Complementing this trio of papers is a recent study in Genome Research that further substantiates the contention that repetitive elements contribute to structural variation (Ewing and Kazazian, 2010) .
Huang and colleagues perform transposon insertion profiling by microarray (TIP-chip) to make a genome-wide map of human L1(Ta) retrotransposons, a younger class of LINE-1 repetitive elements. They identified numerous new human L1(Ta) insertional polymorphisms. Their data suggest that the occurrence of new insertions is twice as high as previously estimated; they calculate one insertion in every 108 births. Interestingly, they explored L1(Ta)s in 69 unrelated male probands with X-linked intellectual disability and identify an intronic insertion in the DACH2 gene, the ortholog of the dachshund gene that regulates neuronal differentiation in fruit flies. Mammalian Dach2 is highly expressed in fetal brain relative to other tissues, and mapping studies have implicated it as a potential locus for intellectual disability. Obviously more work needs to be done to prove causation, but it is important to note that no current diagnostic assays are able to evaluate either de novo repetitive sequence insertions in introns or CNVs of repetitive sequences (i.e., dimorphic polymorphism) given that interrogating oligonucleotides are unique sequence probes. Recent mutation surveys of >200 unrelated males from families with X-linked intellectual disability that screened for either exonic coding region sequence variations (SNVs) or CNVs identified apparent causative alleles in less than half of the families; clearly Retrotransposition and Structural Variation in the Human Genome James R. Lupski 1, *
